← Back to news
April 15, 2026
FDA to Review Restrictions on Popular Peptide Injections
- The FDA will meet in July to discuss easing restrictions on seven peptide injections, including BPC-157 and TB-500, which are popular among wellness influencers.
- Health Secretary Robert F. Kennedy Jr. has publicly advocated for loosening regulations, citing personal benefits from peptide use.
- The FDA plans to remove these peptides from a high-risk drug list, raising concerns about safety and the potential for an unregulated market.
- Critics warn that allowing these peptides without thorough testing poses significant risks to public health.
2 Sources
- FDA will consider easing limits on another RFK Jr wellness fad: peptidesApr 15, 2026 at 2:55 PM · Independent
- FDA will consider easing restrictions on peptides touted by RFK Jr., MAHA figuresApr 16, 2026 at 12:10 AM · CBS News